Ohad Hammer

Ohad Hammer is a Partner at Pontifax Venture Capital in Israel, with a strong background in biotechnology and life sciences. He has successfully invested in a variety of companies at different stages, including Adcytherix, AgomAb Therapeutics, and Precirix, showcasing his expertise in identifying promising ventures and supporting their growth. With a Master's and Bachelor's degree from Tel Aviv University, Ohad has transitioned from a researcher at the university to an Analyst and now a Partner at Pontifax, where he focuses on investing in health and hospital services, biotech, and startups in Israel, demonstrating his strong commitment to advancing innovative technologies and therapies in the pharmaceutical industry.